<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Pharmacol.</journal-id>
<journal-title>Frontiers in Pharmacology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Pharmacol.</abbrev-journal-title>
<issn pub-type="epub">1663-9812</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">778221</article-id>
<article-id pub-id-type="doi">10.3389/fphar.2022.778221</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Pharmacology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Rhein Protects Against Severe Acute Pancreatitis <italic>In vitro</italic> and <italic>In vivo</italic> by Regulating the JAK2/STAT3 Pathway</article-title>
<alt-title alt-title-type="left-running-head">Yang et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Rhein, Severe Acute Pancreatitis, JAK2/STAT3</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Xiaofang</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1481794/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Geng</surname>
<given-names>Huan</given-names>
</name>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1515717/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>You</surname>
<given-names>Lijiao</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yuan</surname>
<given-names>Lin</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Meng</surname>
<given-names>Jialei</given-names>
</name>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Yuhui</given-names>
</name>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Gu</surname>
<given-names>Xuelian</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Lei</surname>
<given-names>Ming</given-names>
</name>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
</contrib>
</contrib-group>
<aff>
<institution>Department of Critical Care Medicine</institution>, <institution>Seventh People&#x2019;s Hospital Affiliated to Shanghai University of Traditional Chinese Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/298388/overview">Henrique Melo Coutinho</ext-link>, Regional University of Cariri, Brazil</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1505597/overview">Fabr&#xed;cio Souza Silva</ext-link>, Federal University of S&#xe3;o Francisco Valley, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1637622/overview">Luiz Jardelino de Lacerda Neto</ext-link>, Federal University of Campina Grande, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1641782/overview">Andreza Ramos</ext-link>, Federal University of Campina Grande, Brazil</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Xuelian Gu, <email>18930837717@163.com</email>; Ming Lei, <email>leiming6891@163.com</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this&#x20;work</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Gastrointestinal and Hepatic Pharmacology, a section of the journal Frontiers in Pharmacology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>03</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>778221</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>02</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Yang, Geng, You, Yuan, Meng, Ma, Gu and Lei.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Yang, Geng, You, Yuan, Meng, Ma, Gu and Lei</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Rhein is widely used in inflammation treatment in China, but its effects on severe acute pancreatitis (SAP) have not been studied closely. This study investigated rhein&#x2019;s protective effects against SAP using <italic>in&#x20;vitro</italic> and <italic>in vivo</italic> models to determine whether its protective mechanism regulated the Janus kinase two and signal transducer and activator of transcription 3 (JAK2/STAT3) signalling pathway. Thirty-six male Sprague&#x2013;Dawley rats were randomised into sham operation, SAP and rhein groups. The SAP model was induced by retrograde pancreatic bile duct injection of sodium taurocholate. Serum TNF-&#x3b1; and interleukin (IL)-6 levels were determined by ELISA, whereas serum amylase and lipase concentrations were measured using test kits. Western blot and/or immunohistochemistry quantified JAK2 and STAT3 expression. Furthermore, histopathological pancreatic changes were detected by haematoxylin and eosin staining. AR42J cells were randomly divided into the control, cerulein and rhein groups. Amylase activity was assessed using an amylase test kit; the tumour necrosis factor-<italic>&#x3b1;</italic> (TNF-&#x3b1;) expression was determined by enzyme-linked immunosorbent assay (ELISA). JAK2 and STAT3 protein expression were evaluated by western blot. SAP was concomitant with increased JAK2 and STAT3 expressions <italic>in vivo</italic>. Pre-treatment with rhein attenuated serum TNF&#x2013;&#x3b1; and IL-6 levels effectively, and notably reduced p-JAK2, p-STAT3, JAK2 and STAT3 protein expression. Rhein significantly alleviated pancreatic histopathology. Compared to untreated groups, rhein significantly reduced amylase activity in supernatants of AR42J cells induced by cerulein <italic>in&#x20;vitro</italic>. Furthermore, rhein altered JAK2 and STAT3 protein levels in AR42J cells after cerulein induction. Overall, rhein exerted protective effect on SAP <italic>in&#x20;vitro</italic> and <italic>in vivo</italic>, possibly through the JAK2/STAT3 signalling pathway.</p>
</abstract>
<kwd-group>
<kwd>rhein</kwd>
<kwd>severe acute pancreatitis</kwd>
<kwd>JAK2/STAT3</kwd>
<kwd>TNF-&#x3b1;</kwd>
<kwd>IL-6</kwd>
</kwd-group>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Acute pancreatitis is an acute inflammatory disease that severely affects health and threatens life, and about 30% of patients with acute pancreatitis progress to severe acute pancreatitis (SAP) (<xref ref-type="bibr" rid="B24">Lankisch and Lerch, 2006</xref>; <xref ref-type="bibr" rid="B29">Morel et&#x20;al., 2006</xref>). About 15%&#x2013;20% of SAP cases often develop multiple systemic complications, such as the liver, intestine, kidneys and lungs complications, and the therapeutic effects of current treatments are unsatisfactory (<xref ref-type="bibr" rid="B57">Zerem, 2014</xref>).</p>
<p>Some studies propose that the effective inhibition of inflammation is key to preventing SAP progression (<xref ref-type="bibr" rid="B13">Gallmeier et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B2">Andersson et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B21">Ivanenkov et&#x20;al., 2011</xref>). Therefore, cell signalling pathways related to inflammation in SAP have been the subject of increased research attention. The Janus kinase two and signal transducer and activator of transcription 3 (JAK2/STAT3) signalling pathway, one of the main cytokine signalling pathways, has become a hotspot of pancreatic research in recent years. The JAK2/STAT3 signalling pathway is widely involved in disease physiology and pathogenic development, including intracellular homeostasis, immune response, cell proliferation and apoptosis (<xref ref-type="bibr" rid="B31">O&#x2019;shea, 2004</xref>). Tumour necrosis factor-<italic>&#x3b1;</italic> (TNF-&#x3b1;) and interleukin (IL)-6 are important transduction factors in the JAK2/STAT3 signalling pathway that can induce the inflammatory cascade, enhance the inflammatory effect and even lead to organ damage and multiple organ dysfunction syndrome in SAP (<xref ref-type="bibr" rid="B66">Zhu et&#x20;al., 2017</xref>). Moreover, the JAK2/STAT3 signalling pathway amplifies the inflammatory response by initiating a series of inflammatory factor transmissions and related protein expression, thereby creating a waterfall effect. Several previous studies have shown that the JAK2/STAT3 pathway plays a key role in inflammatory diseases (<xref ref-type="bibr" rid="B66">Zhu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B42">Xia et&#x20;al., 2021</xref>). Thus, inhibiting this pathway may restrain the expansion of early cascading inflammatory response and prevent acute inflammatory injury to related tissues.</p>
<p>The current treatment protocol for SAP is a multi-targeted therapy based on the diagnostic and treatment guidelines for SAP, which focuses on pharmacological blockade of necrosis, inflammation and cellular damage in the pancreas. The multi-targeted action of natural drugs has attracted attention, compared to the single-targeted action of western drugs (<xref ref-type="bibr" rid="B48">Xue et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B39">Weng et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B43">Xia et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B64">Zhong, 2015</xref>). Rhein is also a natural molecule and is widely found in medicinal plants such as rhubarb, <italic>Sennae folium</italic>, <italic>Semen cassiae</italic>, and <italic>Polygonum multiflorum</italic>, and it is widely used in clinical practice (<xref ref-type="bibr" rid="B44">Xian et&#x20;al., 2020</xref>). In China, approximately 10% (800) of more than 8,000 proprietary Chinese medicines contain rhubarb.</p>
<p>Rhein (the chemical structure is shown in <xref ref-type="fig" rid="F1">Figure&#x20;1</xref>, the main rhubarb component, is reported to be widely used in inflammation treatment in China (<xref ref-type="bibr" rid="B9">Cheng et&#x20;al., 2021</xref>). Rhein is also the major active component in Dachengqi Decoction with strong anti-inflammatory effects (<xref ref-type="bibr" rid="B47">Xu et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B45">Xu et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B45">Xu et&#x20;al., 2010</xref>). Several studies have shown that Dachengqi Decoction can improve the inflammatory response in patients with SAP and reduce pathological pancreatic damage (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B8">Chen et&#x20;al., 2015</xref>). In addition, the JAK2/STAT3 is predicted to be one of the targets of rhein according to network pharmacology. While rhein has been shown to play a prominent role as an inhibitor of the JAK2/STAT3 pathway in several experimental models and human diseases (<xref ref-type="bibr" rid="B60">Zhang et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B50">Yang et&#x20;al., 2019</xref>). However, it is unclear whether rhein has a therapeutic effect on SAP by inhibiting JAK2/STAT3 pathway. Therefore, the present study was designed to investigate rhein&#x2019;s protective effects on SAP using <italic>in&#x20;vitro</italic> and <italic>in vivo</italic> models.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>The chemical structure of rhein.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g001.tif"/>
</fig>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Drugs and Reagents</title>
<p>Purified rhein (Cat. No. 478-43-3) was purchased from the National Institute for Food and Drug Control (Beijing, China), the purity by authorization &#x3e;98%. Sodium taurocholate (Cat. No. T4009), cerulein (Cat. No. C9026) and 5% carboxymethylcellulose sodium (CMCS) (CAS number:9004-32-4) were purchased from Sigma-Aldrich Merck KGaA (Darmstadt, Germany). Amylase kits (Cat. No. C016-1-1) were purchased from Nanjing Jiancheng Institute of Bioengineering (Jiangsu, China). Foetal bovine serum (Cat. No.10099-141), F12K medium (Cat. No. C11330500BT) and trypsin (Cat. No. 25200-056) were purchased from Gibco Ltd. (United&#x20;States). PCR kits (Cat. No. RR820Q) were purchased from TaKaRa Corporation (Japan). GoScript Reverse Transcription Kits (Cat. No. A5001) were purchased from Promega (United&#x20;States). Phosphatase inhibitors (Cat. No. P1081), SDS&#x2013;PAGE gel preparation kits (Cat. No. P0012A) and ECL hypersensitive colour development kits (Cat. No. P0018AS) were purchased from Shanghai Biyuntian Biotechnology (Shanghai, China).</p>
</sec>
<sec id="s2-2">
<title>Cellular Model</title>
<p>Rat pancreatic acinar AR42J cells were obtained from the American Type Culture Collection and were cultured in F12K medium (Cat. No. C11330500BT, Gibco) supplemented with 20% Australian foetal bovine serum (Cat. No. 10099141C, Gibco), 100 U/ml penicillin and 100&#xa0;mg/l streptomycin (Cat. No. 15140-122, Gibco) at 37&#xb0;C and 5% CO<sub>2</sub>. The AR42J cells were divided into three groups: control group, cerulein group (cerulein 10<sup>&#x2013;8</sup>&#xa0;mol/L) (<xref ref-type="bibr" rid="B25">Lee et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B67">Huang et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B56">Yu et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B62">Zhao et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2019</xref>) and rhein group (final concentration 0.25, 0.5 and 1&#xa0;&#x3bc;g/ml). The AR42J cells density was 5&#xd7;10<sup>6</sup>/ml. In the cerulein group, cells and culture supernatants were collected at 0, 0.5, 1, 2, 4, 6, 12 and 24&#xa0;h after the addition of cerulein.</p>
<p>Animal Model Thirty-six adult male Sprague&#x2013;Dawley rats (8&#x2013;10&#x20;weeks old, weighing 200&#x2013;250&#xa0;g) were obtained from the Shanghai SLAC Laboratory Animal Co., Ltd. SD rats were randomly divided into three groups: sham operation group (n &#x3d; 12), SAP model group (<italic>n</italic>&#x20;&#x3d; 12), rhein (dissolved in 0.5% CMCS) treatment group (<italic>n</italic>&#x20;&#x3d; 12). All rats were maintained under standardised conditions on a 12&#xa0;h light/dark cycle and allowed free access to food and water. The rats fasted for 12&#xa0;h before the operation, however, drinking water was available ad libitum. The SAP model was induced via a standardised pressure-controlled infusion of 3.5% sodium taurocholate (1&#xa0;ml/kg, 0.1&#xa0;ml/min) into the bile&#x2013;pancreatic duct, and the common hepatic duct was closed with a small clamp for 5&#xa0;min as previously described (<xref ref-type="bibr" rid="B34">P&#xe9;rez et&#x20;al., 2015</xref>). Subsequently, the clamp was removed, and the abdomen was closed. Rats in the sham control group underwent the same operative procedure with the injection of 0.9% saline in the pancreatic duct. In the rhein group, rats were given rhein by a gastric gavage (30&#xa0;mg/kg, 0.5&#xa0;ml/100&#xa0;g) (<xref ref-type="bibr" rid="B44">Xian et&#x20;al., 2020</xref>) once a day for 7&#xa0;days prior to establishing the SAP model. Each group was orally administered with by gavage rhein (30&#xa0;mg/kg) or saline for seven continuous days. All samples were collected 24&#xa0;h after operation. All protocols and procedures were established in compliance with the US National Institute of Health Guidelines for the Care and Use of Laboratory Animals. They were approved by the Animal Care and Use Committee of Shanghai University of Traditional Chinese Medicine (Protocol number: PSHUTCM200103002).</p>
<p>Amylase, IL-6, TNF-&#x3b1;, lipase And myeloperoxidase Assays.</p>
<p>Amylase (Cat. No. C016-1-1), lipase (Cat. No. A054-2-1) and myeloperoxidase (Cat. No. A044-1-1) were purchased from Nanjing Jiancheng Institute of Bioengineering (Jiangsu, China). Serum amylase, lipase and myeloperoxidase concentrations were measured using test kits according to the manufacturer&#x2019;s instructions. The amounts of TNF-&#x3b1; (Cat. No. E-EL-M0049c) and IL-6 (Cat. No. E-EL-R0015c) were determined using ELISA kits (eBioscience Ltd., United&#x20;States) according to the manufacturer&#x2019;s instructions.</p>
</sec>
<sec id="s2-3">
<title>Western Blot</title>
<p>RIPA lysis buffer was added to pancreatic tissues and centrifuged at 13,700&#xd7; <italic>g</italic> at 4&#xb0;C for 15&#xa0;min. Supernatants were harvested, and the BCA protein kit was used to determine each protein sample&#x2019;s protein content. SDS&#x2013;PAGE gels (10% separating gel, 3% concentrating gel) were prepared. After electrophoresis, the protein was transferred to a PVDF membrane, which was then sealed using 5% BSA for 2&#xa0;h at room temperature. The following primary antibodies were added and incubated at 4&#xb0;C overnight: JAK2 (Cat. No. 3230, 1:1,000, Cell Signaling Technology Inc.), STAT3 (Cat. No. 12640, 1:2000, Cell Signaling Technology Inc.), p-JAK2 (Cat. No. 3776, 1:1,000, Cell Signaling Technology Inc.), p-STAT3 (Cat. No. 9145, 1:1,000, Cell Signaling Technology Inc.) and GAPDH (Cat. No. 5174, 1:1,000, Cell Signaling Technology Inc). The membranes were then washed with Tris-Buffered Saline Tween buffer three times for 10&#xa0;min and incubated with horseradish peroxidase (HRP)-labelled goat anti-rabbit IgG secondary antibody (Cat. No. 7074P2, 1:3,000, Cell Signaling Technology Inc.) for 2&#xa0;h at room temperature. Afterwards, the membranes were washed with Tris-Buffered Saline Tween buffer three times for 10&#xa0;min. Ultra-sensitive ECL luminescence solution was then added to detect the proteins, and a Fluorchem FC3 gel imager was used for detection. ImageJ 1.52a software was used to determine the gray value of the band.&#x20;.</p>
</sec>
<sec id="s2-4">
<title>Pathological Changes in the Pancreas</title>
<p>The rat pancreatic tissues were fixed in 4% paraformaldehyde and embedded in paraffin wax for routine sections. The sample was cut into 5&#xa0;&#xb5;m thick sections. After staining with haematoxylin and eosin, the sections were photographed under the microscope (Nikon FCI IPSE NI, Nikon Corporation) at &#xd7;200 magnification for image processing and analysis. Pancreatic histopathology was scored by the double-blind method (<xref ref-type="bibr" rid="B35">Schmidt et&#x20;al., 1992</xref>). The mean total score of each histopathological variable was subsequently calculated.</p>
<p>The methods of histological score of pancreatic injury were as follows: Edema: 0, absent; 1, focal expansion of the interlobar septa; and 2, diffuse expansion of the interlobar septa. vascular: 0, absent; 1, congestion; 2, congestion plus local interlobar or intralobar hemorrhage; 3, multifocal diffuse hemorrhage; and 4, vascular fibrinoid necrosis or thrombosis. Fat necrosis: 0, absent; 1, focal dissolution of the interlobular or peripancreatic fat; and 2, diffuse dissolution of the interlobular or peripancreatic fat. Acinar necrosis: 0, absent; 1, &#x3c;10% patchy necrosis of the edges of the lobules; 2, 10&#x2013;30% patchy, peripheral necrosis of the lobules; 3, &#x3c;30% confluent lobules necrosis; 4, &#x3c;50% confluent lobular necrosis; and 5, formation of microabscesses. Calcification: 0, absent; 1, focal in fat or acinar necrosis; and 2, diffuse in fat or acinar necrosis.</p>
</sec>
<sec id="s2-5">
<title>Immunohistochemistry</title>
<p>The rat pancreatic tissues slices were dewaxed with xylene, dehydrated with an ethanol gradient, and then placed in a sodium citrate buffer solution for 15&#xa0;min. The slices were cooled for 30&#xa0;min and then treated with 3% hydrogen peroxide for 10&#xa0;min at room temperature. After three washing with PBS (phosphate buffer saline), shook off the PBS before adding antibody to each slice. The following antibodies were added and incubated at 4&#xb0;C overnight: p-JAK2 (Cat. No. ab32101, 1:50, Abacam Company), p-STAT3 (Cat. No. ab267373, 1:250, Abacam Company), After three washings with PBS, the HRP-labelled goat anti-rabbit IgG secondary antibody was added and incubated at room temperature for 1&#xa0;h. The tissue sections were then covered with DAB solution. After colour development, the sections were rinsed with water. Hematoxylin stained for 1&#xa0;min 20&#xa0;s, then soaked in tap water, alcohol fractionated in 1% hydrochloric acid for 1&#xa0;s, soaked in tap water and rinsed under running water for 7&#x2013;8&#xa0;min, dried at 65&#xb0; for 30&#xa0;min, then taken out and cooled to room temperature and sealed in neutral gum. Image processing and photography, two different observers calculated the positive&#x20;areas.</p>
</sec>
<sec id="s2-6">
<title>Molecular Docking</title>
<p>Rhein was preprocessed by the Ligprep 3.6 program (Schr&#xf6;dinger, LLC, New York, NY, United&#x20;States) applying OPLS_2005 force field before molecular docking, with Epik 3.4 (Schr&#xf6;dinger, LLC, New York, NY, United&#x20;States) to generate the proper protonation states at pH 7.0&#x20;&#xb1; 2.0. A restrained minimization of the crystal structure was performed to reorient side-chain hydroxyl groups before further processing. The DQX pocket of 3KRR was selected to define and generate the receptor grid. In silico docking was performed by Glide 6.9 (Schr&#xf6;dinger, LLC, New York, NY, United&#x20;States) in standard precision (SP) with default values for other parameters.</p>
<p>Statistical Analysis Statistical analyses of the obtained experimental data was carried out using SPSS version 21.0. ImageJ 1.52a software was used to calculate the greyscale value. Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. Data are expressed as mean&#x20;&#xb1; SD, and <italic>p</italic>&#x20;&#x3c; 0.05 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<p>The network pharmacology results of rhein with JAK2 molecule.</p>
<p>3KRR is a Crystal Structure of JAK2 complexed with a potent quinoxaline ATP site inhibitor (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). The pocket factor of 3KRR was mostly buried in the hydrophobic pocket of DQX, and its main body forms abundant hydrophobic interactions with surrounding residues, whereas its head forms hydrogen bonds with residues nearby the entrance and middle position of the pocket. The in&#x20;silico docking models showed that the binding sites of the rhein was located near the entrance and middle part of the 3KRR pocket, find rhein partially overlapping with that of the pocket factor of Tyrosine 931 (TYR-931) and MET-929 (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>, <xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>), they may play an important role in the interaction of compounds with pockets, by preempting residue positions and thus achieving the ability to inhibit other compounds from binding to&#x20;them.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>The structure-activity relationships of rhein with JAK2 molecule. <bold>(A)</bold> Schematic diagram of the connection between jAk2 and 3kRR in the software pymol view, 3kRR is a compound structure that can already bind to JAK2. <bold>(B)</bold> Schematic diagram of docking with the pocket after rhein is replaced by 3KRR through molecular docking. <bold>(C)</bold> The residues in the pocket TYR-931 and MET-929 are the residues in the pocket, which they are stable binding sites for&#x20;rhein.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g002.tif"/>
</fig>
<sec id="s3-1">
<title>The Effect of Rhein on Inflammatory Cytokines Levels in SAP Rats</title>
<p>
<xref ref-type="fig" rid="F3">Figure&#x20;3</xref> shows the effect of rhein on the level of inflammatory cytokines in pancreatic tissue of SAP rat model. Compared with the control group, the levels of serum amylase, serum TNF-&#x3b1;, serum IL-6, myeloperoxidase and serum lipase were significantly increased in the SAP group (<italic>p</italic>&#x20;&#x3c; 0.001). After rhein treatment, the levels of serum amylase, serum TNF-&#x3b1;, serum IL-6, myeloperoxidase and serum lipase were significantly decreased in the rhein group compared with the SAP group (<italic>p</italic>&#x20;&#x3c; 0.001).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Effects of rhein on the inflammatory cytokine levels in pancreatic tissue of the SAP rat model. <bold>(A)</bold> Serum amylase levels in the SO, SAP and rhein groups. <bold>(B)</bold> Serum TNF-&#x3b1; levels in the SO, SAP and rhein groups. <bold>(C)</bold> Serum IL-6 levels in the SO, SAP and rhein groups. <bold>(D)</bold> Myeloperoxidase levels in the SO, SAP and rhein groups. <bold>(E)</bold> Serum lipase levels in the SO, SAP and rhein groups. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 5 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SO group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SAP group. SO, sham operation; SAP, severe acute pancreatitis; TNF-&#x3b1;, tumour necrosis factor-<italic>&#x3b1;</italic>; IL-6, interleukin-6.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g003.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>Effect of Rhein on Pathological Dmage in Pancreatic Tissue of SAP Rats</title>
<p>
<xref ref-type="fig" rid="F4">Figure&#x20;4</xref> shows the protective effect of rhein on pancreatic injury. In the control group, typical normal acinar architecture were observed. Only minimal focal edema was detected, and no apparent inflammatory infiltration was found. Compared with the control group, edema, necrosis and inflammatory infiltration were observed in the acinar cells of pancreatic tissue in the SAP group. Compared with the SAP group, less infiltration of inflammatory cells was observed in the rhein group, Only fewer abnormal acinar cells were detected. <xref ref-type="fig" rid="F4">Figure&#x20;4D</xref> reveals that the pathological scores were significantly increased in the SAP group compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.01). Compared with the SAP group, the pathological scores were significantly decreased in the rhein group (<italic>p</italic>&#x20;&#x3c;&#x20;0.05).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Histological analysis of SAP. (<bold>A&#x2013;C)</bold> Morphological analysis of H&#x26;E-stained sections; Scale bar: 100&#xa0;&#x3bc;m. <bold>(D)</bold> Pathological scores of pancreatic tissue sections. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 3 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SO group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SAP group. SO, sham operation; SAP, severe acute pancreatitis; H&#x26;E, haematoxylin and eosin.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g004.tif"/>
</fig>
</sec>
<sec id="s3-3">
<title>Effects of Rhein on p-JAK2, p-STAT3, JAK2 and STAT3 Expression in Pancreatic Tissue of SAP Rats</title>
<p>
<xref ref-type="fig" rid="F5">Figure&#x20;5</xref> indicates that p-JAK2 and p-STAT3 expression were significantly increased in the SAP group compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.001). After rhein treatment, the activity of p-JAK2 and p-STAT3 were significantly decreased compared with the SAP group (<italic>p</italic>&#x20;&#x3c; 0.001). <xref ref-type="fig" rid="F6">Figure&#x20;6</xref> shows that p-JAK2, JAK2, p-STAT3 and STAT3 proteins expression were significantly increased in the SAP group compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.001). This increasing trend was significantly reversed by treatment with rhein (<italic>p</italic>&#x20;&#x3c; 0.001). These phenomena suggest that four proteins closely related to the JAK2/STAT3 signalling pathway are activated in the pancreatic tissue of SAP&#x20;rats.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Immunohistochemical analysis of p-JAK2 and p-STAT3 in pancreatic tissues. <bold>(A)</bold> Representative immunohistochemistry images of p-JAK2 and p-STAT3 in pancreatic tissues 24&#xa0;h after the induction of SAP; Scale bar: 25&#xa0;&#x3bc;m. <bold>(B)</bold> Positive cell ratio of pancreatic tissue sections. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 3 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SO group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SAP group. JAK2, janus kinase two; STAT3, signal transducer and activator of transcription three; SO, sham operation; SAP, severe acute pancreatitis.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g005.tif"/>
</fig>
<fig id="F6" position="float">
<label>FIGURE 6</label>
<caption>
<p>Effects of rhein on p-JAK2, p-STAT3, JAK2 and STAT3 expression in pancreatic tissue of SAP rats. <bold>(A,B)</bold> p-JAK2 and JAK2 protein expression in the SO, SAP and rhein groups. <bold>(C,D)</bold> p-STAT3 and STAT3 protein expression in the SO, SAP and rhein groups. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 5 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SO group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the SAP group. JAK2, janus kinase two; STAT3, signal transducer and activator of transcription three; SO, sham operation; SAP, severe acute pancreatitis.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g006.tif"/>
</fig>
</sec>
<sec id="s3-4">
<title>Establishment of AR42J Pancreatic Acinar Cell Injury Model Induced by Cerulein</title>
<p>We constructed an <italic>in&#x20;vitro</italic> cell model mimicking SAP by treating the AR42J cells line with cerulein to stimulate pro-inflammatory cytokine expression. <xref ref-type="fig" rid="F7">Figure&#x20;7A</xref> reveals that amylase activity increased significantly at 4 h, and then gradually increased at 6, 12 and 24&#xa0;h. <xref ref-type="fig" rid="F7">Figures 7B&#x2013;D</xref> shows that JAK2, STAT3, p-JAK2 and p-STAT3 protein expression gradually increased and peaked at 4&#xa0;h (<italic>p</italic>&#x20;&#x3c; 0.001), to gradually decrease at 6, 12 and 24&#xa0;h. Therefore, we chose 4&#xa0;h as the checkpoint for sample collection of cells in the succeeding experiments. These results suggested that the AR42J cell injury model was successfully established.</p>
<fig id="F7" position="float">
<label>FIGURE 7</label>
<caption>
<p>AR42J cell injury model established by cerulein treatment. <bold>(A)</bold> The amylase activity was measured at different time points. <bold>(B,C)</bold> Western blot findings of p-JAK2, JAK2, p-STAT3 and STAT3 protein expression in AR42J cells treated with cerulein. <bold>(D)</bold> Peak of p-JAK2, JAK2, p-STAT3 and STAT3 proteins expression at different simultaneous phase sites. <bold>(E)</bold> amylase activity in the control, cerulein, rhein 0.25&#xa0;&#x3bc;g/ml, rhein 0.5&#xa0;&#x3bc;g/ml and rhein 1&#xa0;&#x3bc;g/ml groups <bold>(F)</bold> The TNF-&#x3b1; levels in the control, cerulein, rhein 0.25&#xa0;&#x3bc;g/ml, rhein 0.5&#xa0;&#x3bc;g/ml and rhein 1&#xa0;&#x3bc;g/ml groups. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 5 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. JAK2, janus kinase two; STAT3, signal transducer and activator of transcription 3.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g007.tif"/>
</fig>
<p>
<xref ref-type="fig" rid="F7">Figure&#x20;7E</xref> shows that the amylase activity in the cerulein group was significantly upregulated compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.001). When rhein was added to the supernatants of cells at concentrations of 0.25, 0.5 and 1&#xa0;&#x3bc;g/ml 20&#xa0;min before adding cerulein, the amylase level downregulated in a concentration-dependent manner (<italic>p</italic>&#x20;&#x3c; 0.001). <xref ref-type="fig" rid="F7">Figure&#x20;7F</xref> reveals that the TNF-&#x3b1; level in the cerulein group was significantly upregulated compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.001). This increasing trend was significantly reversed by treatment with rhein in a concentration-dependent manner (<italic>p</italic>&#x20;&#x3c; 0.001). These results suggested that rhein protected the injured AR42J&#x20;cells.</p>
</sec>
<sec id="s3-5">
<title>Effect of Rhein on the AR42J Cell Injury Model</title>
<p>Effect Of Rhein On JAK2 and STAT3 Expressions In The AR42J Cell Injury Model <xref ref-type="fig" rid="F8">Figure&#x20;8</xref> shows that p-JAK2, JAK2, p-STAT3 and STAT3 proteins expression were significantly increased in the cerulein group compared with the control group (<italic>p</italic>&#x20;&#x3c; 0.001). After rhein treatment, the activity of p-JAK2, JAK2, p-STAT3 and STAT3 were significantly decreased compared with the cerulein group (<italic>p</italic>&#x20;&#x3c; 0.001). The expression of p-JAK2, JAK2, p-STAT3and STAT3 proteins at the middle and lower doses in the rhein group differed significantly from those at the high dose. These results suggest that rhein could inhibit the expression of protein p-JAK2, JAK2, p-STAT3and STAT3, which are important components in the JAK2/STAT3 signalling transduction pathway induced by cerulein in AR42J&#x20;cells.</p>
<fig id="F8" position="float">
<label>FIGURE 8</label>
<caption>
<p>The protein expression of p-JAK2, JAK2, p-STAT3 and STAT3 in the AR42J cell model was measured by western blot. <bold>(A,B)</bold> p-JAK2 and JAK2 protein expression in the control, cerulein, rhein 0.25&#xa0;&#x3bc;g/ml, rhein 0.5&#xa0;&#x3bc;g/ml and rhein 1&#xa0;&#x3bc;g/ml groups. <bold>(C,D)</bold> p-STAT3 and STAT3 protein expression in the control, cerulein, rhein 0.25&#xa0;&#x3bc;g/ml, rhein 0.5&#xa0;&#x3bc;g/ml and rhein 1&#xa0;&#x3bc;g/ml groups. Data are expressed as mean&#x20;&#xb1; SD (<italic>n</italic>&#x20;&#x3d; 5 per group). Significance between groups was evaluated by one way analysis of variance (ANOVA) followed by a Tukey post hoc test. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 and &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001 compared with the control group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>&#x23;&#x23;&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the cerulein group; <sup>$</sup>
<italic>p</italic>&#x20;&#x3c; 0.05, <sup>$$</sup>
<italic>p</italic>&#x20;&#x3c; 0.01 and <sup>$$$</sup>
<italic>p</italic>&#x20;&#x3c; 0.001 compared with the rhein 0.25&#xa0;&#x3bc;g/ml group. JAK2, janus kinase two; STAT3, signal transducer and activator of transcription 3.</p>
</caption>
<graphic xlink:href="fphar-13-778221-g008.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>In the current study, we found that rhein significantly alleviated pancreatic histopathology, attenuated proinflammation factors, and inhibited JAK2/STAT3 signalling pathway in SAP rat model. In SAP cell model, rhein significantly decreased the expression of amylase and TNF-&#x3b1; induced by cerulein, and inhibited JAK2/STAT3 signalling pathway.</p>
<p>The pathogenesis of SAP seems to be related to multifaceted pathological processes, involving inflammation, parenchymal acinar cell death by necrosis, and cellular damage in the pancreas. We established SAP rat models by retrograde pancreatic bile duct injection of sodium taurocholate (<xref ref-type="bibr" rid="B33">Pereda et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B41">Wu et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">P&#xe9;rez et&#x20;al., 2015</xref>). However, under the action of sodium taurocholate, pancreatic acinar cells are damaged and the inflammatory response is enhanced, which may activate various disease-related signalling pathways, such as the JAK2/STAT3 signalling pathway (<xref ref-type="bibr" rid="B4">Booth et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B20">Husain et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B28">Lerch and Gorelick, 2013</xref>). Conversely, crosstalk between acinar cells and the immune system perpetuates the inflammatory response. These pathways amplify the production of proinflammatory cytokines, including TNF-&#x3b1;, IL-1 &#x3b2;, IL-6 and IL-18 (<xref ref-type="bibr" rid="B28">Lerch and Gorelick, 2013</xref>; <xref ref-type="bibr" rid="B1">Abu-El-Haija and Lowe, 2018</xref>; <xref ref-type="bibr" rid="B27">Lee and Papachristou, 2019</xref>). The SAP cell model was induced by cerulein. Pathological changes similar to those of human SAP were found during the induction (<xref ref-type="bibr" rid="B55">Yu et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B26">Lee et&#x20;al., 2010</xref>). Because cerulein is a CCK analogue, it binds to CCK receptors to activate signal transduction in pancreatic acinar cells. The CCK2 receptor is a Gq protein-coupled receptor that mediates JAK2/STAT3 activation and promotes pancreatic tumour cell proliferation (<xref ref-type="bibr" rid="B11">Ferrand et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B12">Ferrand et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B3">Beales and Ogunwobi, 2009</xref>). Previous studies have shown that cerulein induces IL-1&#x3b2; expression in pancreatic acinar cells by activating the JAK2/STAT3 signalling pathway (<xref ref-type="bibr" rid="B54">Yu et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B53">Yu et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B65">Zhou et&#x20;al., 2021</xref>). Therefore, relieving pancreatic inflammation and inhibiting activated JAK2/STAT3 should be included in new-generation of drugs for&#x20;SAP.</p>
<p>Traditional Chinese medicine has rich experience in the prevention and treatment of SAP. At present, it has been reported that Dachengqi Decoction plays an important role in reducing the complications of SAP in patients (<xref ref-type="bibr" rid="B59">Zhang et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B37">Wan et&#x20;al., 2011</xref>). In SAP rats treated with Dachengqi Decoction and rhubarb, the distribution characteristics of five main anthraquinone compounds of rhubarb (rhein, emodin methyl ether, rhubarb phenol, aloe-emodin and emodin) in pancreas were studied, rhein is the most abundant component of all anthraquinones detected in pancreatic tissue (<xref ref-type="bibr" rid="B63">Zhao et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B15">Gong et&#x20;al., 2009</xref>). However, the research on the inhibitory effect of the above traditional Chinese medicine on SAP is often limited to the determination of inflammatory factors and pharmacodynamics, and there is a lack of in-depth research on its mechanism.</p>
<p>At present, natural products with low side effects and efficacy have been considered for the treatment of SAP. In SAP model, huperzine II treatment was able to increase antioxidant, anti-inflammatory and anti-apoptotic activity (<xref ref-type="bibr" rid="B69">Piao et&#x20;al., 2017</xref>), possibly by activating the farnesoid X receptor or affecting the JAK2/STAT3 signalling pathway to reduce oxidative, inflammatory and apoptotic levels (<xref ref-type="bibr" rid="B68">Li et&#x20;al., 2020</xref>), thus providing protection for SAP. Another study also indicated that curcumin ameliorates acute renal injury in a rat model of SAP. The molecular mechanism of its effect may be associated with the suppression of the JAK2/STAT3 pathway to reduce TNF-&#x3b1; and IL-6 levels in SAP-induced acute renal injury. Rhein is a natural molecule and our results showed that it inhibited the JAK2/STAT3 signalling pathway, and caused a decrease in inflammatory factor levels, these results consistent with the predicted target results of network pharmacology. Besides, Rhein is widely found in medicinal plants such as rhubarb, <italic>Sennae folium</italic>, <italic>Semen cassiae</italic>, and <italic>Polygonum multiflorum</italic>, and it is widely used in clinical practice (<xref ref-type="bibr" rid="B44">Xian et&#x20;al., 2020</xref>). These medical plants are broadly used all over the world. In China, approximately 10% (800) of more than 8,000 proprietary Chinese medicines contain rhubarb. So, rhein has extremely important value in the treatment of&#x20;SAP.</p>
<p>Nowadays, rhein is widely used in inflammation treatment in China (<xref ref-type="bibr" rid="B22">Ji and Gu, 2021</xref>; <xref ref-type="bibr" rid="B38">Wang et&#x20;al., 2020</xref>). In this study, in order to investigate whether rhein possessed anti-inflammatory effects in a rat model of SAP, we first established a rat model of SAP. In our current study, SAP model was established in rats by retrograde pancreatic bile duct injection of sodium taurocholate with a dose of 3.5% (<xref ref-type="bibr" rid="B33">Pereda et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B41">Wu et&#x20;al., 2013</xref>; <xref ref-type="bibr" rid="B34">P&#xe9;rez et&#x20;al., 2015</xref>). Then the model was tested by pathological damage and inflammatory cytokines. For pancreatic injury, we tested it by HE staining. Edema, necrosis and inflammatory infiltration were observed in the acinar cells of pancreatic tissue. These alterations can be attributed to the action of sodium taurocholate. However, under the action of sodium taurocholate, pancreatic acinar cells are damaged and the inflammatory response is enhanced, which may activate various disease-related signalling pathways, such as the JAK2/STAT3 signalling pathway (<xref ref-type="bibr" rid="B4">Booth et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B20">Husain et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B28">Lerch and Gorelick, 2013</xref>). Previous studies have reported that the JAK2/STAT3 pathway plays a key role in inflammatory diseases (<xref ref-type="bibr" rid="B66">Zhu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B42">Xia et&#x20;al., 2021</xref>). Therefore, the JAK2/STAT3 signalling pathway plays a crucial role in evaluating potential mechanism. In this work, p-JAK2, JAK2, p-STAT3 and STAT3 proteins expression were significantly increased in the SAP group compared with the control group. The above-mentioned findings indicated that a SAP rat model was successfully established.</p>
<p>After rhein treatment, inflammatory cytokines were decreased, and JAK2/STAT3 signalling pathway related proteins were also downregulated, suggesting that rhein plays an anti-inflammatory role by inhibiting JAK2/STAT3 signaling pathway. In addition, HE staining is another method frequently used in evaluation of pancreatic injury (<xref ref-type="bibr" rid="B38">Wang et&#x20;al., 2020</xref>). In the current study, the protective effects of rhein were further validated by the significantly improved histological results. The histopathological changes were significantly restored by rhein treatment, and less infiltration of inflammatory cells was observed in the rhein group compared with the model group. These findings also provided convincing evidence that rhein exerted protective effects against sodium taurocholate-induced pancreatic injury.</p>
<p>According to published many literatures about rhein anti-inflammatory mechanism, such as the interactive relationships of rhein on multiple inflammatory signaling pathways and cellular processes (<xref ref-type="bibr" rid="B38">Wang et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B10">Ding et&#x20;al., 2020</xref>) The SAP cell model was induced by cerulein in AR42J cells, which pathological changes similar to those of human SAP were found during the induction (<xref ref-type="bibr" rid="B55">Yu et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B26">Lee et&#x20;al., 2010</xref>). AR42J cells were treated with 10<sup>&#x2212;8</sup>&#xa0;mol/L of cerulein for 24&#xa0;h. Then the model was tested by inflammatory cytokines and JAK2/STAT3 signalling pathway related proteins at 4&#xa0;h. These alterations can be attributed to the action of cerulein. In this work, amylase and TNF-&#x3b1; activity in the SAP group were significantly upregulated compared with the control group, and p-JAK2, JAK2, p-STAT3 and STAT3 proteins expression were significantly increased in the SAP group compared with the control group. The above-mentioned findings indicated that SAP cell model was successfully established. After rhein treatment, inflammatory cytokines were downregulated, and JAK2/STAT3 signalling pathway related proteins were also decreased, suggesting that rhein plays an anti-inflammatory role by regulating JAK2/STAT3 signaling pathway.</p>
<p>In summary, rhein not only inhibits the release of inflammatory factors but also alters the expression of JAK2/STAT3 signal pathway-related proteins in the SAP model <italic>in vivo</italic> and <italic>in&#x20;vitro</italic>. Our findings indicate the potential therapeutic effects of rhein on&#x20;SAP.</p>
</sec>
<sec sec-type="conclusion" id="s5">
<title>Conclusion</title>
<p>Taken together, our data provided evidence that rhein plays therapeutic role by inhibiting therelease of inflammatory factors in the SAP model <italic>in vivo</italic> and <italic>in&#x20;vitro</italic>. This effect may be related to the regulation of JAK2/STAT3 signal pathway. This study will be helpful for the treatment of&#x20;SAP.</p>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7">
<title>Ethics Statement</title>
<p>The present study was approved by the Animal Care and Use Committee of Shanghai University of Traditional Chinese Medicine. Written informed consent was obtained from the owners for the participation of their animals in this study.</p>
</sec>
<sec id="s8">
<title>Author Contributions</title>
<p>XG and ML designed the study and revised the manuscript. XY, HG, LY, YM, LY, and JM performed the experiments, XY and HG conducted the data analysis and drafted the manuscript. All authors have read and approved the final manuscript.</p>
</sec>
<sec id="s9">
<title>Funding</title>
<p>This work was supported by the funded by Medical discipline Construction Project of Pudong Health Committee of Shanghai (Grant No.PWYgy2021-06), the National Natural Science Foundation of China (No.81973649), Emphasis Subspeciality of Shanghai Pudong (PWZy2020-07), the Leading Medical Talent Training Program of Pudong Health Bureau of Shanghai (PWR12019-02), the National Natural Science Foundation of China (No.8217141990), Shanghai University of Traditional Chinese Medicine &#x201C;Postgraduate Innovation Training Special Project (Y2021022)&#x201D;, Shanghai Municipal Commission of Health and Wellness - Federation of Chinese and Western Medicine Burn Trauma Specialists (ZY(2021-2023)-0302).</p>
</sec>
<sec sec-type="COI-statement" id="s10">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abu-El-Haija</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Lowe</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Pediatric Pancreatitis-Molecular Mechanisms and Management</article-title>. <source>Gastroenterol. Clin. North. Am.</source> <volume>47</volume>, <fpage>741</fpage>&#x2013;<lpage>753</lpage>. <pub-id pub-id-type="doi">10.1016/j.gtc.2018.07.003</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andersson</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Andersson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Axelsson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Eckerwall</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tingstedt</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Acute Pancreatitis-Ffrom Cellular Signalling to Complicated Clinical Course</article-title>. <source>HPB (Oxford)</source> <volume>9</volume>, <fpage>414</fpage>&#x2013;<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1080/13651820701713766</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Beales</surname>
<given-names>I. L.</given-names>
</name>
<name>
<surname>Ogunwobi</surname>
<given-names>O. O.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Glycine-extended Gastrin Inhibits Apoptosis in Barrett&#x27;s Oesophageal and Oesophageal Adenocarcinoma Cells through JAK2/STAT3 Activation</article-title>. <source>J.&#x20;Mol. Endocrinol.</source> <volume>42</volume>, <fpage>305</fpage>&#x2013;<lpage>318</lpage>. <pub-id pub-id-type="doi">10.1677/JME-08-0096</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Booth</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Mukherjee</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Awais</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Neoptolemos</surname>
<given-names>J.&#x20;P.</given-names>
</name>
<name>
<surname>Gerasimenko</surname>
<given-names>O. V.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Reactive Oxygen Species Induced by Bile Acid Induce Apoptosis and Protect against Necrosis in Pancreatic Acinar Cells</article-title>. <source>Gastroenterology</source> <volume>140</volume>, <fpage>2116</fpage>&#x2013;<lpage>2125</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2011.02.054</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brands</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>Banes-Berceli</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Inscho</surname>
<given-names>E. W.</given-names>
</name>
<name>
<surname>Al-Azawi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Allen</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Labazi</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Interleukin 6 Knockout Prevents Angiotensin II Hypertension: Role of Renal Vasoconstriction and Janus Kinase 2/signal Transducer and Activator of Transcription 3 Activation</article-title>. <source>Hypertension</source> <volume>56</volume>, <fpage>879</fpage>&#x2013;<lpage>884</lpage>. <pub-id pub-id-type="doi">10.1161/hypertensionaha.110.158071</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jia</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Diao</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z. X.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.&#x20;B.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Effects of Traditional Chinese Medicine on Intestinal Mucosal Permeability in Early Phase of Severe Acute Pancreatitis</article-title>. <source>Chin. Med. J.&#x20;(Engl)</source> <volume>123</volume>, <fpage>1537</fpage>&#x2013;<lpage>1542</lpage>. <pub-id pub-id-type="doi">10.3760/cma.j.issn.0366-6999.2010.12.011</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Rosiglitazone Prevents Acute Pancreatitis through Inhibiting microRNA-26a Expression</article-title>. <source>Exp. Ther. Med.</source> <volume>18</volume>, <fpage>1246</fpage>&#x2013;<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2019.7711</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Dachengqi Decoction Attenuates Inflammatory Response via Inhibiting HMGB1 Mediated NF-&#x39a;b and P38 MAPK Signaling Pathways in Severe Acute Pancreatitis</article-title>. <source>Cell Physiol Biochem</source> <volume>37</volume>, <fpage>1379</fpage>&#x2013;<lpage>1389</lpage>. <pub-id pub-id-type="doi">10.1159/000430403</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Pi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>A Research Update on the Therapeutic Potential of Rhein and its Derivatives</article-title>. <source>Eur. J.&#x20;Pharmacol.</source> <volume>899</volume>, <fpage>173908</fpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2021.173908</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Anti-Inflammatory Efficacy of Fabricated Rhein Micelles</article-title>. <source>J.&#x20;Biomed. Nanotechnol</source> <volume>16</volume>, <fpage>1463</fpage>&#x2013;<lpage>1470</lpage>. <pub-id pub-id-type="doi">10.1166/jbn10.1166/jbn.2020.2982</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrand</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kowalski-Chauvel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bertrand</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Escrieut</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Mathieu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Portolan</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>A Novel Mechanism for JAK2 Activation by a G Protein-Coupled Receptor, the CCK2R: Implication of This Signaling Pathway in Pancreatic Tumor Models</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>280</volume>, <fpage>10710</fpage>&#x2013;<lpage>10715</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m413309200</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrand</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vatinel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kowalski-Chauvel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bertrand</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Escrieut</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Fourmy</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Mechanism for Src Activation by the CCK2 Receptor: Patho-Physiological Functions of This Receptor in Pancreas</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>12</volume>, <fpage>4498</fpage>&#x2013;<lpage>4503</lpage>. <pub-id pub-id-type="doi">10.1055/s-2006-92684410.3748/wjg.v12.i28.4498</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gallmeier</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Sch&#xe4;fer</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Moubarak</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Tietz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Pl&#xf6;ssl</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Huss</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>JAK and STAT Proteins Are Expressed and Activated by IFN-Gamma in Rat Pancreatic Acinar Cells</article-title>. <source>J.&#x20;Cel Physiol</source> <volume>203</volume>, <fpage>209</fpage>&#x2013;<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.20216</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gjessing</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1972</year>). <article-title>Renal Failure in Acute Pancreatitis</article-title>. <source>Br. Med. J.</source> <volume>4</volume>, <fpage>359</fpage>&#x2013;<lpage>360</lpage>. <pub-id pub-id-type="doi">10.1136/bmj.4.5836.359-b</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gong</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Effect of Severe Acute Pancreatitis on Pharmacokinetics of Da-Cheng-Qi Decoction Components</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>15</volume>, <fpage>5992</fpage>&#x2013;<lpage>5999</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.15.5992</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanayama</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tanaka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shinohara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iwamatsu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nagata</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Identification of a Factor that Links Apoptotic Cells to Phagocytes</article-title>. <source>Nature</source> <volume>417</volume>, <fpage>182</fpage>. <pub-id pub-id-type="doi">10.1038/417182a</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname>
<given-names>Z. J.</given-names>
</name>
<name>
<surname>Matikainen</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Alho</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Harmoinen</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ahola</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Nordback</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Extrapancreatic Organ Impairment in Caerulein Induced Pancreatitis</article-title>. <source>Ann. Chir Gynaecol.</source> <volume>88</volume>, <fpage>112</fpage>&#x2013;<lpage>117</lpage>. <pub-id pub-id-type="doi">10.1055/s-1999-7281</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hirano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Manabe</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>A Possible Mechanism for Gallstone Pancreatitis: Repeated Short-Term Pancreaticobiliary Duct Obstruction with Exocrine Stimulation in Rats</article-title>. <source>Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med.</source> <volume>202</volume>, <fpage>246</fpage>. <pub-id pub-id-type="doi">10.3181/00379727-202-43534</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horiguchi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asano</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kuroda</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sato</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Asakuma</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>STAT3 Inhibitor WP1066 as a Novel Therapeutic Agent for Renal Cell Carcinoma</article-title>. <source>Br. J.&#x20;Cancer</source> <volume>102</volume>, <fpage>1592</fpage>&#x2013;<lpage>1599</lpage>. <pub-id pub-id-type="doi">10.1038/sj.bjc.6605691</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L. X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. P.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y. Z.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>SFractalkine Upregulates Inflammation Through CX3CR1 and the Jak-Stat Pathway in Severe Acute Pancreatitis rat Model</article-title>. <source>Inflammation</source> <volume>35</volume>, <fpage>1023</fpage>&#x2013;<lpage>1030</lpage>. <pub-id pub-id-type="doi">10.1007/s10753-011-9406-5</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Husain</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Orabi</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Muili</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sarwar</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mahmood</surname>
<given-names>S. M.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Ryanodine Receptors Contribute to Bile Acid-Induced Pathological Calcium Signaling and Pancreatitis in Mice</article-title>. <source>Am. J.&#x20;Physiol. Gastrointest. Liver Physiol.</source> <volume>302</volume>, <fpage>G1423</fpage>&#x2013;<lpage>G1433</lpage>. <pub-id pub-id-type="doi">10.1152/ajpgi.00546.2011</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ivanenkov</surname>
<given-names>Y. A.</given-names>
</name>
<name>
<surname>Balakin</surname>
<given-names>K. V.</given-names>
</name>
<name>
<surname>Lavrovsky</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Small Molecule Inhibitors of NF-kB and JAK/STAT Signal Transduction Pathways as Promising Anti-inflammatory Therapeutics</article-title>. <source>Mini Rev. Med. Chem.</source> <volume>11</volume>, <fpage>55</fpage>&#x2013;<lpage>78</lpage>. <pub-id pub-id-type="doi">10.2174/138955711793564079</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ji</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Anti-obesity Effects of Rhein on Improving Insulin Resistance (IR) and Blood Lipid Levels Are Involved in Endoplasmic Reticulum Stress (ERs), Inflammation, and Oxidative Stress <italic>In Vivo</italic> and Vitro</article-title>. <source>Bioengineered</source> <volume>12</volume>, <fpage>5797</fpage>&#x2013;<lpage>5813</lpage>. <pub-id pub-id-type="doi">10.1080/2165597910.1080/21655979.2021.1969196</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ju</surname>
<given-names>K. D.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Potential Role of NADPH Oxidase-Mediated Activation of Jak2/Stat3 and Mitogen-Activated Protein Kinases and Expression of TGF-&#x392;1 in the Pathophysiology of Acute Pancreatitis</article-title>. <source>Inflamm. Res.</source> <volume>60</volume>, <fpage>791</fpage>&#x2013;<lpage>800</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-011-0335-4</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lankisch</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>Lerch</surname>
<given-names>M. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Pharmacological Prevention and Treatment of Acute Pancreatitis: where Are We Now?</article-title> <source>Dig. Dis.</source> <volume>24</volume>, <fpage>148</fpage>&#x2013;<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1159/000090318</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>J.&#x20;B.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Signal Transduction of Cerulein-Induced Cytokine Expression and Apoptosis in Pancreatic Acinar Cells</article-title>. <source>Ann. N. Y Acad. Sci.</source> <volume>1010</volume>, <fpage>104</fpage>&#x2013;<lpage>108</lpage>. <pub-id pub-id-type="doi">10.1196/annals.1299.017</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Membrane Proteome Analysis of Cerulein-Stimulated Pancreatic Acinar Cells: Implication for Early Event of Acute Pancreatitis</article-title>. <source>Gut liver</source> <volume>4</volume>, <fpage>84</fpage>&#x2013;<lpage>93</lpage>. <pub-id pub-id-type="doi">10.5009/gnl.2010.4.1.84</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Papachristou</surname>
<given-names>G. I.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>New Insights into Acute Pancreatitis</article-title>. <source>Nat. Rev. Gastroenterol. Hepatol.</source> <volume>16</volume>, <fpage>479</fpage>&#x2013;<lpage>496</lpage>. <pub-id pub-id-type="doi">10.1038/s41575-019-0158-2</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lerch</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Gorelick</surname>
<given-names>F. S.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Models of Acute and Chronic Pancreatitis</article-title>. <source>Gastroenterology</source> <volume>144</volume>, <fpage>1180</fpage>&#x2013;<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1053/j.gastro.2012.12.043</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Farnesoid X Receptor Activation Induces Antitumour Activity in Colorectal Cancer by Suppressing JAK2/STAT3 Signalling via Transactivation of SOCS3 gene</article-title>. <source>J. Cell. Mol. Med.</source> <volume>24</volume>, <fpage>14549</fpage>&#x2013;<lpage>14560</lpage>. <pub-id pub-id-type="doi">10.1111/jcmm.16083</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morel</surname>
<given-names>D. R.</given-names>
</name>
<name>
<surname>Frossard</surname>
<given-names>J.&#x20;L.</given-names>
</name>
<name>
<surname>Cikirikcioglu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tapponnier</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pastor</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Time Course of Lung Injury in Rat Acute Pancreatitis</article-title>. <source>Intensive Care Med.</source> <volume>32</volume>, <fpage>1872</fpage>&#x2013;<lpage>1880</lpage>. <pub-id pub-id-type="doi">10.1007/s00134-006-0264-9</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Norman</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>The Role of Cytokines in the Pathogenesis of Acute Pancreatitis</article-title>. <source>Am. J.&#x20;Surg.</source> <volume>175</volume>, <fpage>76</fpage>. <pub-id pub-id-type="doi">10.1016/S0002-9610(97)00240-7</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x27;shea</surname>
<given-names>J.&#x20;J.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Targeting the Jak/STAT Pathway for Immunosuppression</article-title>. <source>Ann. Rheum. Dis.</source> <volume>63 Suppl 2</volume>, <fpage>ii67</fpage>&#x2013;<lpage>ii71</lpage>. <pub-id pub-id-type="doi">10.1136/ard.2004.028290</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tolbert</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Ponnusamy</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>A Novel STAT3 Inhibitor, S3I-201, Attenuates Renal Interstitial Fibroblast Activation and Interstitial Fibrosis in Obstructive Nephropathy</article-title>. <source>Kidney Int.</source> <volume>78</volume>, <fpage>257</fpage>&#x2013;<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1038/ki.2010.154</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pereda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sabater</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cassinello</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>G&#xf3;mez-Cambronero</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Closa</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Folch-Puy</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Effect of Simultaneous Inhibition of TNF-Alpha Production and Xanthine Oxidase in Experimental Acute Pancreatitis: the Role of Mitogen Activated Protein Kinases</article-title>. <source>Ann. Surg.</source> <volume>240</volume>, <fpage>108</fpage>&#x2013;<lpage>116</lpage>. <pub-id pub-id-type="doi">10.1097/01.sla.0000129343.47774.89</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>P&#xe9;rez</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Pereda</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Sabater</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sastre</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Pancreatic Ascites Hemoglobin Contributes to the Systemic Response in Acute Pancreatitis</article-title>. <source>Free Radic. Biol. Med.</source> <volume>81</volume>, <fpage>145</fpage>&#x2013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2014.08.008</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>&#x03BA;Picroside II Shows Protective Functions for Severe Acute Pancreatitis in Rats by Preventing NF-B-Dependent Autophagy</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>7085709</volume>. <pub-id pub-id-type="doi">10.1155/2017/7085709</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidt</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Rattner</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Lewandrowski</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Compton</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Mandavilli</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Knoefel</surname>
<given-names>W. T.</given-names>
</name>
<etal/>
</person-group> (<year>1992</year>). <article-title>A Better Model of Acute Pancreatitis for Evaluating Therapy</article-title>. <source>Ann. Surg.</source> <volume>215</volume>, <fpage>44</fpage>&#x2013;<lpage>56</lpage>. <pub-id pub-id-type="doi">10.1097/00000658-199201000-00007</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vona-Davis</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Frankenberry</surname>
<given-names>K. A.</given-names>
</name>
<name>
<surname>Waheed</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>McFadden</surname>
<given-names>D. W.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Expression of STAT3 and SOCS3 in Pancreatic Acinar Cells</article-title>. <source>J.&#x20;Surg. Res.</source> <volume>127</volume>, <fpage>14</fpage>&#x2013;<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1016/j.jss.2005.03.019</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wan</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Xue</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G. Y.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Clinical Observation on the Effect of Dexamethasone and Chinese Herbal Decoction for Purgation in Severe Acute Pancreatitis Patients</article-title>. <source>Chin. J.&#x20;Integr. Med.</source> <volume>17</volume>, <fpage>141</fpage>&#x2013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1007/s11655-011-0630-5</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Anti-inflammatory Effects and Mechanisms of Rhein, an Anthraquinone Compound, and its Applications in Treating Arthritis: A Review</article-title>. <source>Nat. Prod. Bioprospect</source> <volume>10</volume>, <fpage>445</fpage>&#x2013;<lpage>452</lpage>. <pub-id pub-id-type="doi">10.1007/s13659-020-00272-y</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weng</surname>
<given-names>T. I.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B. L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>S. H.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Honokiol Attenuates the Severity of Acute Pancreatitis and Associated Lung Injury via Acceleration of Acinar Cell Apoptosis</article-title>. <source>Shock</source> <volume>37</volume>, <fpage>478</fpage>&#x2013;<lpage>484</lpage>. <pub-id pub-id-type="doi">10.1097/SHK.0b013e31824653be</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>San-Huang-Xie-Xin-Tang Constituents Exert Drug-Drug Interaction of Mutual Reinforcement at Both Pharmacodynamics and Pharmacokinetic Level: A Review</article-title>. <source>Front. Pharmacol.</source> <volume>7</volume>, <fpage>448</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2016.00448</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>S. Z.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>B. C.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Da-Huang-Fu-Zi-Tang Attenuates Liver Injury in Rats with Severe Acute Pancreatitis</article-title>. <source>J.&#x20;Ethnopharmacol</source> <volume>150</volume>, <fpage>960</fpage>&#x2013;<lpage>966</lpage>. <pub-id pub-id-type="doi">10.1016/j.jep.2013.09.051</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Limonin Ameliorates Acute Pancreatitis by Suppressing JAK2/STAT3 Signaling Pathway</article-title>. <source>Environ. Toxicol.</source> <volume>36</volume>, <fpage>2392</fpage>&#x2013;<lpage>2403</lpage>. <pub-id pub-id-type="doi">10.1002/tox.23352</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>X. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>B. K.</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Ruan</surname>
<given-names>H. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Emodin Promoted Pancreatic Claudin-5 and Occludin Expression in Experimental Acute Pancreatitis Rats</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>18</volume>, <fpage>2132</fpage>&#x2013;<lpage>2139</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v18.i17.213210.3748/wjg.v18.i17.2132</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xian</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effects of Rhein on Bile Acid Homeostasis in Rats</article-title>. <source>Biomed. Res. Int.</source> <volume>2020</volume>, <fpage>8827955</fpage>. <pub-id pub-id-type="doi">10.1155/2020/8827955</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Constituents of Da-Cheng-Qi Decoction and its Parent Herbal Medicines Determined by LC-MS/MS</article-title>. <source>Nat. Prod. Commun.</source> <volume>5</volume>, <fpage>789</fpage>&#x2013;<lpage>794</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.20090024410.1177/1934578x1000500522</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>HPLC/DAD Comparison of Sixteen Bioactive Components between Da-Cheng-Qi Decoction and its Parent Herbal Medicines</article-title>. <source>Nat. Prod. Commun.</source> <volume>5</volume>, <fpage>893</fpage>&#x2013;<lpage>896</lpage>. <pub-id pub-id-type="doi">10.1007/s00044-009-9208-6</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Rapid Simultaneous Quantification of Five Active Constituents in Rat Plasma by High-Performance Liquid Chromatography/tandem Mass Spectrometry after Oral Administration of Da-Cheng-Qi Decoction</article-title>. <source>J.&#x20;Pharm. Biomed. Anal.</source> <volume>47</volume>, <fpage>586</fpage>&#x2013;<lpage>595</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2008.02.005</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Adjusting Effects of Baicalin for Nuclear Factor-kappaB and Tumor Necrosis Factor-Alpha on Rats with Caerulein-Induced Acute Pancreatitis</article-title>. <source>Mediators Inflamm.</source> <volume>2006</volume>, <fpage>26295</fpage>. <pub-id pub-id-type="doi">10.1155/mi/2006/26295</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>D. Y.</given-names>
</name>
<name>
<surname>Fushimi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>S. Q.</given-names>
</name>
<name>
<surname>Komatsu</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Molecular Analysis of Rheum Species Used as Rhei Rhizoma Based on the Chloroplast Matk Gene Sequence and its Application for Identification</article-title>. <source>Biol. Pharm. Bull.</source> <volume>27</volume>, <fpage>375</fpage>. <pub-id pub-id-type="doi">10.1248/bpb.27.375</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Rhein Sensitizes Human Pancreatic Cancer Cells to Egfr Inhibitors by Inhibiting Stat3 Pathway</article-title>. <source>J.&#x20;Exp. Clin. Cancer Res.</source> <volume>38</volume>, <fpage>31</fpage>. <pub-id pub-id-type="doi">10.1186/s13046-018-1015-9</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Duan</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Daphnetin Ameliorates Acute Lung Injury in Mice with Severe Acute Pancreatitis by Inhibiting the JAK2-STAT3 Pathway</article-title>. <source>Sci. Rep.</source> <volume>11</volume>, <fpage>11491</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-021-91008-6</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fei</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Blockade of C3a/C3aR axis Alleviates Severe Acute Pancreatitis-Induced Intestinal Barrier Injury</article-title>. <source>Am. J.&#x20;Transl Res.</source> <volume>12</volume>, <fpage>6290</fpage> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>SOCS 3 and PPAR-Gamma Ligands Inhibit the Expression of IL-6 and TGF-Beta1 by Regulating JAK2/STAT3 Signaling in Pancreas</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol</source> <volume>40</volume>, <fpage>677</fpage>&#x2013;<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2007.10.007</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Suppression of IL-1beta Expression by the Jak 2 Inhibitor AG490 in Cerulein-Stimulated Pancreatic Acinar Cells</article-title>. <source>Biochem. Pharmacol.</source> <volume>72</volume>, <fpage>1555</fpage>&#x2013;<lpage>1562</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2006.07.008</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>J.&#x20;Y.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Differentially Expressed Proteins in Cerulein-Stimulated Pancreatic Acinar Cells: Implication for Acute Pancreatitis</article-title>. <source>Int. J.&#x20;Biochem. Cel Biol</source> <volume>40</volume>, <fpage>503</fpage>&#x2013;<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1016/j.biocel.2007.09.001</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Yun</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>K. H.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Proteome Analysis of Rat Pancreatic Acinar Cells: Implication for Cerulein-Induced Acute Pancreatitis</article-title>. <source>Proteomics</source> <volume>3</volume>, <fpage>2446</fpage>&#x2013;<lpage>2453</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200300545</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zerem</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Treatment of Severe Acute Pancreatitis and its Complications</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>20</volume>, <fpage>13879</fpage>&#x2013;<lpage>13892</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v20.i38.13879</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>H. Y.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>X. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Astragaloside &#x2163; Inhibits Jak2/stat3 Signaling Pathway and Alleviates Severe Acute Pancreatitis-Associated Acute Liver Injury in Rats</article-title>. <source>Chin. J.&#x20;Pathophysiology</source>. <pub-id pub-id-type="doi">10.3969/j.issn.1000-4718.2016.06.004</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Ni</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Treatment of Abdominal Compartment Syndrome in Severe Acute Pancreatitis Patients with Traditional Chinese Medicine</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>14</volume>, <fpage>3574</fpage>&#x2013;<lpage>3578</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.14.3574</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Formula Compatibility Identification of Dachengqi Decoction Based on the Effects of Absorbed Components in Cerulein-Injured Pancreatic Ar42j Cells</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>2016</volume>, <fpage>3198549</fpage>. <pub-id pub-id-type="doi">10.1155/2016/3198549</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Pharmacokinetic and Pharmacodynamic Studies of Four Major Phytochemical Components of Da-Cheng-Qi Decoction to Treat Acute Pancreatitis</article-title>. <source>J.&#x20;Pharmacol. Sci.</source> <volume>122</volume>, <fpage>118</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1254/jphs.13037FP</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wan</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Rhein Induces a Necrosis-Apoptosis Switch in Pancreatic Acinar Cells</article-title>. <source>Evid. Based Complement. Alternat Med.</source> <volume>2014</volume>, <fpage>404853</fpage>. <pub-id pub-id-type="doi">10.1155/2014/404853</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X. H.</given-names>
</name>
<name>
<surname>Ito</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Qian</surname>
<given-names>J.&#x20;M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Protective Effects of Rhubarb on Experimental Severe Acute Pancreatitis</article-title>. <source>World J.&#x20;Gastroenterol.</source> <volume>10</volume>, <fpage>1005</fpage>&#x2013;<lpage>1009</lpage>. <pub-id pub-id-type="doi">10.3748/wjg.v10.i7.1005</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Curcumin Mediates a Protective Effect via TLR-4/nf-&#x39a;b Signaling Pathway in Rat Model of Severe Acute Pancreatitis</article-title>. <source>Cell Biochem. Biophys.</source> <volume>73</volume>, <fpage>175</fpage>&#x2013;<lpage>180</lpage>. <pub-id pub-id-type="doi">10.1007/s12013-015-0664-y</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Da Cheng Qi Decoction Alleviates Cerulein-Stimulated AR42J Pancreatic Acinar Cell Injury via the JAK2/STAT3 Signaling Pathway</article-title>. <source>Evid Based. Complement. Altern. Med.</source> <volume>2021</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1155/2021/6657036</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Ye</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Curcumin Protects against Acute Renal Injury by Suppressing JAK2/STAT3 Pathway in Severe Acute Pancreatitis in Rats</article-title>. <source>Exp. Ther. Med.</source> <volume>14</volume>, <fpage>1669</fpage>&#x2013;<lpage>1674</lpage>. <pub-id pub-id-type="doi">10.3892/etm.2017.4647</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>